Ontology highlight
ABSTRACT: Importance
Patient-specific human leukocyte antigen (HLA) genomic loss (HLA loss) is one of the reputed mechanisms of leukemia immune escape and relapse after haploidentical hematopoietic stem cell transplant (HSCT). However, clinical characteristics and prognosis of this distinct relapse type in the setting of haploidentical HSCT based on antithymocyte globulin (ATG) T-cell-replete conditioning are still unknown, especially for patients with lymphoid leukemia.Objective
To identify the incidence of and patient characteristics associated with HLA loss at hematologic cancer relapse after ATG-based haploidentical HSCT and to assess overall survival after HLA loss at relapse.Design, setting, and participants
This retrospective and multicenter case series study used data
SUBMITTER: Wu H
PROVIDER: S-EPMC8987901 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature